MedPath

Carbidopa and Levodopa

Carbidopa and Levodopa Tablets, USP Ronly

Approved
Approval ID

4ced8a05-27ac-463f-b331-387e473fdaa1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 13, 2022

Manufacturers
FDA

Aurobindo Pharma Limited

DUNS: 650082092

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carbidopa and Levodopa

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59651-456
Application NumberANDA216537
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carbidopa and Levodopa
Product Specifications
Route of AdministrationORAL
Effective DateDecember 13, 2022
FDA Product Classification

INGREDIENTS (8)

CARBIDOPAActive
Quantity: 10 mg in 1 1
Code: MNX7R8C5VO
Classification: ACTIM
CROSPOVIDONE (35 .MU.M)Inactive
Code: 40UAA97IT9
Classification: IACT
HYDROXYPROPYL CELLULOSE (110000 WAMW)Inactive
Code: 5Y0974F5PW
Classification: IACT
LEVODOPAActive
Quantity: 100 mg in 1 1
Code: 46627O600J
Classification: ACTIB
FD&C BLUE NO. 2--ALUMINUM LAKEInactive
Code: 4AQJ3LG584
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

Carbidopa and Levodopa

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59651-457
Application NumberANDA216537
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carbidopa and Levodopa
Product Specifications
Route of AdministrationORAL
Effective DateDecember 13, 2022
FDA Product Classification

INGREDIENTS (8)

CARBIDOPAActive
Quantity: 25 mg in 1 1
Code: MNX7R8C5VO
Classification: ACTIM
CROSPOVIDONE (35 .MU.M)Inactive
Code: 40UAA97IT9
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
LEVODOPAActive
Quantity: 100 mg in 1 1
Code: 46627O600J
Classification: ACTIB
HYDROXYPROPYL CELLULOSE (110000 WAMW)Inactive
Code: 5Y0974F5PW
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT

Carbidopa and Levodopa

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59651-458
Application NumberANDA216537
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carbidopa and Levodopa
Product Specifications
Route of AdministrationORAL
Effective DateDecember 13, 2022
FDA Product Classification

INGREDIENTS (8)

LEVODOPAActive
Quantity: 250 mg in 1 1
Code: 46627O600J
Classification: ACTIB
CARBIDOPAActive
Quantity: 25 mg in 1 1
Code: MNX7R8C5VO
Classification: ACTIM
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYDROXYPROPYL CELLULOSE (110000 WAMW)Inactive
Code: 5Y0974F5PW
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FD&C BLUE NO. 2--ALUMINUM LAKEInactive
Code: 4AQJ3LG584
Classification: IACT
CROSPOVIDONE (35 .MU.M)Inactive
Code: 40UAA97IT9
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carbidopa and Levodopa - FDA Drug Approval Details